UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Family Planning Decision Making in People With Multiple Sclerosis

Frontiers in neurology, 2021-04, Vol.12, p.620772-620772

2021

Volltextzugriff (PDF)

Patient subgroup analyses of the treatment effect of subcutaneous interferon beta -1a on development of multiple sclerosis in the randomized controlled REFLEX study

Journal of neurology, 2014-03, Vol.261 (3), p.490-499

2014

Volltextzugriff (PDF)

Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets

Multiple sclerosis and related disorders, 2020-11, Vol.46, p.102469-102469, Article 102469

2020

Volltextzugriff (PDF)

Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study

Multiple sclerosis, 2022-07, Vol.28 (8), p.1219-1228

2022

Volltextzugriff (PDF)

COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update

Multiple sclerosis and related disorders, 2021-06, Vol.51, p.102929-102929, Article 102929

2021

Volltextzugriff (PDF)

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

Journal of neurology, 2020-06, Vol.267 (6), p.1715-1723

2020

Volltextzugriff (PDF)

Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103264-103264, Article 103264

2021

Volltextzugriff (PDF)

Family planning in people with multiple sclerosis: a plain language summary

Neurodegenerative disease management, 2022-02, Vol.12 (1), p.9-14

2022

Volltextzugriff (PDF)

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

Multiple sclerosis, 2021-03, Vol.27 (3), p.465-474

2021

Volltextzugriff (PDF)

Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a

European journal of neurology, 2022-07, Vol.29 (7), p.2024-2035

2022

Volltextzugriff (PDF)

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis

Multiple sclerosis and related disorders, 2021-11, Vol.56, p.103283-103283, Article 103283

2021

Volltextzugriff (PDF)

Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary

Future oncology (London, England), 2022-02, Vol.12 (1), p.1-7

2022

Volltextzugriff (PDF)

The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summary

Neurodegenerative disease management, 2022-12, Vol.12 (6), p.285-293

2022

Volltextzugriff (PDF)

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

Multiple sclerosis journal - experimental, translational and clinical, 2021-07, Vol.7 (3), p.20552173211024298-20552173211024298

2021

Volltextzugriff (PDF)

Evaluation of nationwide referral pathways, investigation and treatment of suspected cauda equina syndrome in the United Kingdom

British journal of neurosurgery, 2019-11, Vol.33 (6), p.624-634

2019

Volltextzugriff (PDF)

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

Journal of the neurological sciences, 2017-05, Vol.376, p.84-90

2017

Volltextzugriff (PDF)

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

Movement disorders, 2016-05, Vol.31 (5), p.742-747

2016

Volltextzugriff (PDF)

Development of a method to compare microsurgery techniques across different levels of surgical experience

Interdisciplinary neurosurgery : Advanced techniques and case management, 2017-12, Vol.10, p.52-56

2017

Volltextzugriff (PDF)

Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland

Stroke and vascular neurology, 2023-06, Vol.8 (3), p.207-216

2023

Volltextzugriff (PDF)

Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau

Archives of neurology (Chicago), 2012-06, Vol.69 (6), p.709

2012

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaClinical Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Neurosciences & Neurology
(21)
Science & Technology
(21)
Humans
(15)
Multiple Sclerosis
(12)
Multiple Sclerosis - Drug Therapy
(8)
Cladribine Tablets
(6)
Female
(6)
Neurology
(6)
Neurosciences
(6)
Patients
(5)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(4)
Adult
(3)
Clarity
(3)
Male
(3)
Plain Language Summary
(3)
Pregnancy
(3)
Registries
(3)
Treatment Outcome
(3)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Family Planning Decision Making in People With Multiple Sclerosis

Patient subgroup analyses of the treatment effect of subcutaneous interferon beta -1a on development of multiple sclerosis in the randomized controlled REFLEX study

Favorable outcomes after COVID-19 infection in multiple sclerosis patients treated with cladribine tablets

Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study

COVID-19 in patients with multiple sclerosis treated with cladribine tablets: An update

Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry

Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis

Family planning in people with multiple sclerosis: a plain language summary

Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudy

Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta‐1a

Outcomes of COVID-19 among patients treated with subcutaneous interferon beta-1a for multiple sclerosis

Side effects that occurred early in people with multiple sclerosis during the first year of treatment with cladribine tablets: a plain language summary

The effect of cladribine tablets in people with more active multiple sclerosis: a plain language summary

Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosis

Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2

Evaluation of nationwide referral pathways, investigation and treatment of suspected cauda equina syndrome in the United Kingdom

Multicenter observational study of abobotulinumtoxinA neurotoxin in cervical dystonia: The ANCHOR-CD registry

Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

Development of a method to compare microsurgery techniques across different levels of surgical experience

Prospective, multicentre study of screening, investigation and management of hyponatraemia after subarachnoid haemorrhage in the UK and Ireland

Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau

Aktive Filter

Suchergebnisse filtern